×
收藏-健康|会(x)员访问记?/h3>
| |页标题Q? | |
×
注册健康|用?/h3>
| ??名：(x) | ||
|---|---|---|
| ?p?人：(x) | ?nbsp; 别：(x) | |
| ?nbsp; 码：(x) | ||
| 重复密码Q?/th> | ||
| ?sh)子邮箱Q?/th> | ||
| 邮箱验证码：(x) | ||
| 固定?sh)话Q?/th> | ||
| ?nbsp; 真：(x) | ||
| ?nbsp; 机：(x) | ||
| 单位名称Q?/th> | ||
| 通信地址Q?/th> | ||
| 首选栏目：(x) | ||
| 我已l认真阅dƈ同意《健L(fng)服务条款?/a> | ||
| 定注册 | ||
曙方医药引进|见病新药Vamorolone
作者：(x)yuanxc 来源Q互联网 点击敎ͼ(x)0 更新旉Q?022-1-5 16:59:10
[关键字]Q?/font> 曙方医药 Vamorolone License in
健康|讯Q?/FONT>
曙方医药与瑞士Santhera制药宣布?yu)q见病新药Vamorolone达成独家授权协议Q曙方医药获得在华开发和商业化Vamorolone用于杜氏肌营M良（DMDQ及(qing)其他|见病适应症的独家权益?
×
健康|提C?/span>
相关q接
Zhejiang Benli Science & Technology Co., Ltd. added uracil norfloxacin raw materials intermediates to the technical transformation.
Jiangxi Dicuo Pharmaceutical invested in a new project of medicines intermediates with an annual output of 10,520 antiviral drugs.
Weekly Vitamin market review (December 27-December 31 , 2021)
Shandong Tianli Pharmaceuticals annual output of 40,000 tons of vitamin C sodium project was put into operation.
NHU Sinopec invested 3 billion yuan to build methionine project.
NHU vitamin family welcomes "new member" vitamin B12 into production.
At the end of 2021, vitamin products plunged sharply-vitamin B12
卫材与吉利dJAKȀ酶抑制剂JYSELECA{订协议
Jiangxi Dicuo Pharmaceutical invested in a new project of medicines intermediates with an annual output of 10,520 antiviral drugs.
Weekly Vitamin market review (December 27-December 31 , 2021)
Shandong Tianli Pharmaceuticals annual output of 40,000 tons of vitamin C sodium project was put into operation.
NHU Sinopec invested 3 billion yuan to build methionine project.
NHU vitamin family welcomes "new member" vitamin B12 into production.
At the end of 2021, vitamin products plunged sharply-vitamin B12
卫材与吉利dJAKȀ酶抑制剂JYSELECA{订协议